Royalty Pharma plc
$60.96
+1.34 (+2.25%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- +3.4%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -12.1%
Own RPRX?
See how RPRX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.